Product Information
ARISTADA ER 1,064 MG/3.9 ML SYR is a brand product labeled by Alkermes, Inc., priced at $988.9842 per ML under NDC 65757040403. Its NADAC has been published 419 times since Jun 20, 2018.
Strength
1064 mg/3.9mL
Manufacturer
Alkermes, Inc.NDC
65757040403
Classification
Brand
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Last Updated
6/17/2026
Active Ingredients
ARIPIPRAZOLE LAUROXILApproval Type
New Drug (NDA)
FDA Application
NDA207533On Market Since
6/5/2017
Pharmacological Classes
Price Statistics
The NADAC for ARISTADA ER 1,064 MG/3.9 ML SYR has been published 419 times since Jun 20, 2018, and over the history we have for it it has risen 43.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $988.9842 per ML |
|---|---|
| All-time high | $988.9842 (Jun 24, 2026) |
| All-time low | $690.6004 (Jun 20, 2018) |
| 52-week high | $988.9842 |
| 52-week low | $930.8412 |
| Median price | $860.0202 |
| Average price | $852.3175 |
| Largest weekly change | +6.0% (Jan 14, 2026) |
| Weeks tracked | 419 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the aripiprazole lauroxil market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ARISTADA ER 1,064 MG/3.9 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for ARISTADA ER 1,064 MG/3.9 ML SYR, manufactured by Alkermes, Inc., is $988.9842 per ML (NDC 65757040403), effective Jun 24, 2026.
How has the price of ARISTADA ER 1,064 MG/3.9 ML SYR changed over time?
Over the history we have for it, the NADAC for ARISTADA ER 1,064 MG/3.9 ML SYR has risen 43.2%. It has been tracked across 419 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for ARISTADA ER 1,064 MG/3.9 ML SYR?
Since Jun 20, 2018, the NADAC for ARISTADA ER 1,064 MG/3.9 ML SYR has ranged from a low of $690.6004 (Jun 20, 2018) to a high of $988.9842 (Jun 24, 2026), with a median of $860.0202 per ML.
Are there cheaper alternatives to ARISTADA ER 1,064 MG/3.9 ML SYR?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ARISTADA ER 1,064 MG/3.9 ML SYR, so no direct lower-cost alternative is listed.
Who manufactures ARISTADA ER 1,064 MG/3.9 ML SYR?
ARISTADA ER 1,064 MG/3.9 ML SYR (NDC 65757040403) is labeled by Alkermes, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification